Health Care·Health Care Equipment·$45.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.01 | N/A | +40.56% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $2.01 | N/A | +40.56% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed confidence in the company's ability to navigate current market conditions. They emphasized a focus on innovation and customer needs.
Management highlighted strong demand for veterinary diagnostics.
They noted ongoing investments in innovation to drive future growth.
IDEXX Labs reported a strong earnings per share, exceeding expectations significantly, which contributed to a positive stock reaction of nearly 3%. The company is seeing robust demand in its veterinary diagnostics segment, which may bode well for future performance. However, the lack of revenue data and forward guidance leaves some uncertainty for investors.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ON SEMICONDUCTOR COR
Feb 1, 2021